Regular intake of aspirin can reduce the risk of developing skin cancer by 40 percent, according to a new study.
Scientists at the Harvard Medical School are confirmed that taking a daily tablet of the painkiller, for at least five years reduces the risk of melanoma.
"Our data at least supports the hypothesis that long-term steady aspirin use has an effect," the Daily Mail quoted study co-author Dr Robert Stern as telling the MSNBC.
The researchers analyzed and compared the medical records of 1,000 people, only to find that 400 of them had been diagnosed with melanoma - the most lethal form of skin cancer.
On the other hand, people without the disease were found to have a longer history of taking non-steroidal anti-inflammatory drugs (NSAIDS) like aspirin.
However, Dr Maryam Asgari from the University of California San Francisco has contradicted the study, saying that she did not find any evidence supporting NSAID's effect on reducing the risk of developing skin cancer.
The study appears in the Journal of Investigative Dermatology.